What's new

Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised

Apr 29, 2025 - 10:31
 0
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Despite 2024 struggles, THG CEO optimistic after Ingenuity demerger

Next Article

Russian President Vladimir Putin announces three-day cease-fire in Ukraine war

Related Posts

Overview of comments received on guideline on clinical ...

Apr 28, 2025  0

List of eligible industry stakeholder organisations

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0